Duke University-Pratt School of Engineering: Genetic Targeting Gives Cancer Therapy Better Shot at Success
September 17, 2019
September 17, 2019
DURHAM, North Carolina, Sept. 17 [TNSmedicalresearch] -- Duke University's Pratt School of Engineering issued the following news:
* * *
- A promising cancer therapy overcomes the body's innate resistance using CRISPR/Cas targeting and drug delivery gel
* * *
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and . . .
* * *
- A promising cancer therapy overcomes the body's innate resistance using CRISPR/Cas targeting and drug delivery gel
* * *
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and . . .